港交所(00388.HK)逆彈逾4%重越10天線 憧憬更多中概股來港上市
美國監管當局昨晚通過提交審計資料新規,加速中概股退市。市場憧憬將會更多中概股來港上市,藍籌港交所(00388.HK)由逾八個月低急彈重越10天線(446.9元),最高見454.2元(暫受制20天線455.8元),現報450.2元,逆市回升4.2%,成交增至556萬股,涉資24.67億元。
美國證券交易委員會(SEC)昨晚發佈通告指,已通過臨時修正,以執行《外國公司責任法案》(HFCA Act)對上市公司信息披露要求。新規下,外國企業被要求連續3年接受美國會計審查,否則可能會被除牌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.